Craneware (LON:CRW) Sets New 1-Year High at $2,278.00

Shares of Craneware plc (LON:CRW - Get Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 2,278 ($28.14) and last traded at GBX 2,275 ($28.10), with a volume of 50163 shares traded. The stock had previously closed at GBX 2,230 ($27.54).

Wall Street Analyst Weigh In

Separately, Berenberg Bank upped their price target on shares of Craneware from GBX 2,300 ($28.41) to GBX 2,600 ($32.11) and gave the stock a "buy" rating in a research report on Monday, March 4th.

Craneware Stock Up 2.7 %

The firm has a 50 day moving average price of GBX 2,174.80 and a two-hundred day moving average price of GBX 1,899.19. The company has a market capitalization of £809.52 million, a price-to-earnings ratio of 10,823.81 and a beta of 0.14. The company has a quick ratio of 1.00, a current ratio of 0.78 and a debt-to-equity ratio of 19.15.

Craneware Cuts Dividend

The business also recently disclosed a dividend, which was paid on Monday, April 15th. Investors of record on Thursday, March 21st were paid a dividend of GBX 13 ($0.16) per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a yield of 0.62%. Craneware's payout ratio is currently 13,809.52%.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.